TITLE:
      Supplemental Thyroxine Treatment for Preterm Infants With Hypothyroxinemia
SUMMARY:
      In order to determine the efficacy and safety of thyroxine replacement, a randomized
      clinical trial of thyroxine supplementation for VLBW infant with hypothyroxinemia during the
      first month of age is conducted.
DETAILED DESCRIPTION:
      A prospective randomized unmasked controlled trial is conducted. Newborn infants with birth
      weight less than 1500g are randomized into thyroxine treatment or un-treatment group.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Birth weight: less than 1500g

          -  Gestation: 22 weeks 0 day ≤

          -  Serum free thyroxine level lower than 0.8 ng/dl

          -  Serum thyrotropin lower than 10 μU/ml

          -  Age of between 2 and 4 weeks after birth

          -  Informed consent

        Exclusion Criteria:

          -  any known thyroid disease in mother
